CINC Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Name	Title	Email/Phone
1 Daniel Lott	VP Client Marketing	Reveal Email/Phone
2 Jeff Walker	VP Product	Reveal Email/Phone
3 Judy Ryce	Senior Director Billing Operations	Reveal Email/Phone
4 Chelsea Scott	Senior Director Client Implementation, Onboarding & Training	Reveal Email/Phone
5 Jonathan Brown	Director Sales	Reveal Email/Phone
6 Michael Wade	Director	Reveal Email/Phone
7 Matthew Purdie	Director Frontline Support at CINC	Reveal Email/Phone
8 James Terry	Senior Director - Search Engine Marketing	Reveal Email/Phone
9 Mark Lee	Director Client Support	Reveal Email/Phone
10 Richard Kaiser	Director, Demand Generation & Sales Operations	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Ylopo	$34.2M	222	46%	N/A	N/A

Our powerful lead generation and conversion platform keeps you seamlessly engaged with your clients from Hello to Congratulations.

keywords:N/A

N/A

Total Funding

189

Number of Employees

$31.4M

Revenue (est)

Employee Growth %

N/A

Valuation

N/A

Accelerator

Analysts Anticipate CinCor Pharma, Inc. (NASDAQ:CINC) Will Post Earnings of -$0.50 Per Share. Posted by admin on Apr 11th, 2022.

Given this risk, we thought we'd take a look at whether CinCor Pharma (NASDAQ:CINC) shareholders should be worried about its cash burn.

Summary. CINC's single asset is CIN-107 targeting hypertension. The company is well-funded after a solid IPO. A number of data...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Precise Loss Pr...	$41M	193	-2%	N/A
#2 Dimensional Thi...	$26.3M	199	62%	N/A
#3 Martial Art	$55M	200	N/A	N/A
#4 Moore Ingram Jo...	$62.7M	200	12%	N/A
#5 Team Management	$33M	200	N/A	N/A